4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Vivo Bio Tech Limited (VIVOBIOT) operates in the Biotechnology industry and is headquartered in Hyderabad, India with about 247 employees. Its market capitalization is roughly ₹372 million. In the fiscal year ended 2026-03-31, VIVOBIOT reported ₹533M in revenue and (₹17M) in net income.
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹533M | ₹467M | ₹454M | ₹522M | — |
| Gross Profit | ₹452M | ₹409M | ₹416M | ₹455M | — |
| Operating Income (EBIT) | ₹109M | ₹115M | ₹120M | ₹126M | — |
| Net Income | (₹17M) | ₹73M | ₹25M | ₹26M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹143M | ₹142M | ₹135M | ₹131M | ₹125M | — |
| Gross Profit | ₹124M | ₹118M | ₹114M | ₹110M | ₹110M | — |
| Operating Income (EBIT) | ₹15M | ₹23M | ₹28M | ₹28M | ₹28M | — |
| Net Income | ₹2M | (₹52M) | ₹12M | ₹9M | ₹13M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Assets | ₹1.8B | ₹1.4B | ₹1.4B | ₹1.2B |
| Total Liabilities | ₹853M | ₹653M | ₹827M | ₹712M |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VIVOBIOT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms